This website is now the new JPND's archival platform. This website hosts all of JPND's archived content and resources.
Please continue to visit this site to access publications, videos and reports from JPND's activities.
Validating novel ryanodine receptor-targeted compounds for AD therapeutics
Validating novel ryanodine receptor-targeted compounds for AD therapeutics Investments < €500k United States of America 2016
